Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Riverside › NPI 1225038953
Hospital

Parkview Community Hospital Medical Center

Parkview Community Hospital Medical Center was paid $9.21M by Medicaid between Jan 2018 and May 2020, across 171 billing codes. Its largest line is 0450, Emergency room services — 27% of everything it billed.

33Billing provider infoPARKVIEW COMMUNITY HOSPITAL MEDICAL CENTER
RIVERSIDE, CA 92503
33aNPI1225038953assigned 07/22/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.21M
24GClaims315,678
24DCodes billed171
24AFirst – last monthJan 2018 – May 2020
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#187 of 410
Median peer was paid$6.90M
This provider vs. median1.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018148,297$4.24M
2019164,461$4.92M
20202,920$57K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 27% 42,061 36,164 $2.49M
0762 12% 2,965 1,677 $1.08M
70450 Computed tomography, head or brain; without contrast material 6.5% 3,245 3,035 $601K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4.5% 6,060 5,349 $418K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 3.9% 4,952 4,556 $363K
74176 Computed tomography, abdomen and pelvis; without contrast material 3.8% 2,887 2,706 $351K
80053 Comprehensive metabolic panel 2.9% 16,388 14,207 $264K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2.7% 3,424 3,037 $249K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.6% 943 887 $235K
Z7502 2.5% 6,072 5,947 $227K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.3% 18,473 15,878 $211K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.0% 6,302 5,565 $183K
159 more codes
0360 1.8% 1,662 $167K
0750 1.5% 1,272 $141K
71045 Radiologic examination, chest; single view 1.2% 7,723 $110K
96361 Intravenous infusion, hydration; each additional hour 1.1% 4,873 $98K
81025 <1% 10,950 $90K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,255 $87K
72125 Computed tomography, cervical spine; without contrast material <1% 365 $84K
83690 <1% 7,408 $79K
82553 <1% 4,540 $72K
96379 <1% 1,959 $70K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,097 $65K
84484 <1% 4,695 $63K
82150 <1% 6,236 $62K
71046 Radiologic examination, chest; 2 views <1% 2,136 $56K
81003 <1% 16,069 $54K
83880 <1% 2,137 $46K
85730 <1% 5,449 $45K
76801 <1% 665 $44K
82550 <1% 4,716 $41K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 567 $37K
76830 Ultrasound, transvaginal <1% 493 $32K
99284 Emergency room visit (serious) <1% 687 $31K
85610 <1% 5,735 $30K
70486 <1% 136 $29K
J3490 Unclassified drugs <1% 14,553 $28K
74018 <1% 1,314 $28K
99283 Emergency room visit (moderate) <1% 580 $28K
0710 <1% 968 $27K
59025 Fetal non-stress test <1% 1,409 $25K
Z9725 <1% 827 $25K
J7030 Infusion, normal saline solution , 1000 cc <1% 6,173 $24K
84703 <1% 1,947 $22K
93971 <1% 191 $22K
83605 <1% 1,427 $21K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,059 $21K
96375 Therapeutic injection; each additional sequential IV push <1% 602 $20K
82947 <1% 4,287 $20K
99499 <1% 300 $19K
73610 <1% 700 $19K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,387 $19K
73630 <1% 721 $18K
84702 <1% 958 $18K
90715 <1% 526 $18K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 302 $18K
72100 <1% 577 $18K
84443 Thyroid stimulating hormone (TSH) <1% 706 $17K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,857 $16K
Z7610 <1% 1,316 $16K
73130 <1% 579 $16K
99070 <1% 6,526 $15K
87040 <1% 1,039 $14K
73030 <1% 531 $14K
73564 <1% 477 $14K
80048 Basic metabolic panel (calcium, ionized) <1% 1,116 $14K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 646 $14K
87400 <1% 2,090 $12K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,063 $11K
73110 <1% 358 $10K
81001 <1% 1,822 $10K
G0378 Hospital observation service, per hour <1% 38 $9K
71275 Computed tomographic angiography, chest, with contrast material <1% 37 $9K
99285 Emergency room visit (most serious) <1% 130 $9K
87420 <1% 563 $8K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 555 $8K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,390 $8K
72131 <1% 32 $8K
85379 <1% 411 $7K
88313 <1% 659 $7K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,515 $7K
82140 <1% 430 $7K
73080 <1% 238 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 111 $6K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 383 $6K
86901 <1% 977 $6K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 254 $5K
86140 <1% 730 $5K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,425 $5K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,979 $5K
86850 <1% 556 $5K
88312 <1% 612 $5K
A0429 Emergency ambulance ride, basic life support <1% 150 $5K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 462 $4K
73140 <1% 260 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,086 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,755 $4K
83735 <1% 584 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 43 $4K
36415 Collection of venous blood by venipuncture <1% 436 $4K
86900 <1% 976 $4K
12001 <1% 252 $4K
71250 <1% 16 $4K
72040 <1% 119 $3K
82803 <1% 131 $3K
73590 <1% 151 $3K
A4217 Sterile water/saline, 500 ml <1% 504 $3K
J7050 Infusion, normal saline solution, 250 cc <1% 1,774 $3K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 74 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,960 $3K
71010 <1% 166 $3K
29125 <1% 397 $2K
73090 <1% 110 $2K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 185 $2K
93307 <1% 14 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 185 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,456 $2K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 413 $2K
29540 <1% 239 $2K
71020 <1% 58 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 701 $2K
12011 <1% 71 $2K
73562 <1% 70 $2K
29515 <1% 192 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,900 $1K
J2060 Injection, lorazepam, 2 mg <1% 842 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 867 $1K
82010 <1% 100 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 530 $1K
84145 <1% 73 $1K
87088 <1% 146 $1K
80076 <1% 189 $1K
29530 <1% 130 $943.32
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 15 $934.27
74000 <1% 43 $859.80
88307 <1% 41 $834.94
84550 <1% 144 $790.22
0250 <1% 674 $735.65
10060 <1% 42 $728.87
71101 <1% 14 $719.46
85652 <1% 206 $662.12
J0690 Injection, cefazolin sodium, 500 mg <1% 352 $645.21
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 649 $635.35
74022 <1% 12 $587.55
87070 <1% 58 $582.38
E0110 Crutches, forearm, includes crutches of various materials, adjustable or fixed, pair, complete with tips and handgrips <1% 16 $574.89
84100 <1% 116 $565.74
82247 <1% 99 $562.32
29105 <1% 71 $502.38
81015 <1% 260 $421.93
73502 <1% 14 $372.39
0270 <1% 155 $220.82
12002 <1% 15 $210.00
29130 <1% 26 $191.94
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 13 $180.00
29505 <1% 17 $122.22
45381 <1% 13 $100.00
80061 Lipid panel <1% 14 $99.50
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 13 $79.61
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 14 $66.96
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 27 $55.81
J3370 Injection, vancomycin hcl, 500 mg <1% 13 $55.51
J1815 Injection, insulin, per 5 units <1% 43 $54.31
85007 <1% 19 $52.26
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 404 $50.37
89060 <1% 14 $33.96
J1650 Injection, enoxaparin sodium, 10 mg <1% 41 $27.98
A9270 Non-covered item or service <1% 614 $10.34
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 48 $4.09
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 12 $2.60
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 14 $0.13

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDRUMWRIGHT, DOUG (CHEIF EXECUTIVE OFFICER)